PUBLICATIONS

From Traditional Nanoparticles to Cluster-Triggered Emission Polymers for the Generation of Smart Nanotheranostics in Cancer Treatment

Blasco-Navarro, C.; Alonso-Moreno, C.; Bravo, I.Nanotheranostics 2025, 6, 3. https://doi.org/10.3390/jnt6010003

pH-Sensitive Fluorescence Lifetime Molecular Probes Based on Functionalized Tristyrylbenzene

Pedro J. Pacheco-Liñán, Andrés Garzón, Juan Tolosa, Iván Bravo, Jesús Canales-Vázquez, Julián Rodríguez-López, José Albaladejo, Joaquín C. García-Martínez https://doi.org/10.1021/acs.jpcc.6b05526

Spectroscopic study on binding of gentisic acid to bovine serum albumin

Andrés Garzón, Iván Bravo, M. Rosario Carrión-Jiménez, Ángela Rubio-Moraga, José Albaladejo https://doi.org/10.1016/j.saa.2015.05.045

Binding of the anticancer drug BI-2536 to human serum albumin. A spectroscopic and theoretical study

Jesús Fernández-Sainz, Pedro J. Pacheco-Liñán, José M. Granadino-Roldán, Iván Bravo, Andrés Garzón, Jaime Rubio-Martínez, José AlbaladejoJ. Photochemistry & Photobiology, B: Biology, 2017, 172, 77–87;https://doi.org/10.1016/j.jphotobiol.2017.05.016

Effect of the Aggregation on the Photophysical Properties of a Blue-Emitting Star-Shaped Molecule Based on 1,3,5-Tristyrylbenzene

Andrés Garzón, M. Paz Fernández-Liencres, Mónica Moral, Tomás Peña-Ruiz, Amparo Navarro, Juan Tolosa, Jesús Canales-Vázquez, Daniel Hermida-Merino, Iván Bravo, José Albaladejo, Joaquín C. García-Martínez J. Phys. Chem. C 2017, 121, 8, 4720–4733...

Study on the pH Dependence of the Photophysical Properties of a Functionalized Perylene Bisimide and Its Potential Applications as a Fluorescence Lifetime Based pH Probe

Pedro J. Pacheco-Liñán, Mónica Moral, María L. Nueda, Rubén Cruz-Sánchez, Jesús Fernández-Sainz, Andrés Garzón-Ruiz, Iván Bravo, Manuel Melguizo, Jorge Laborda, José Albaladejo J. Phys. Chem. C 2017, 121, 44, 24786–24797...

pH-Controlled Self-Assembly of X-Shaped Conjugated Molecules: The Case of 1,2,4,5-Tetrastyrylbenzene

Rocío Domínguez, Juan Tolosa, Mónica Moral, Iván Bravo, Jesús Canales-Vázquez, Julián Rodríguez-López, Andrés Garzón-Ruiz, Joaquín C. García-Martínez J. Phys. Chem. C 2018, 122, 34, 19937–19945 https://doi.org/10.1021/acs.jpcc.8b05024

Guanidine Substitutions in Naphthyl Systems to Allow a Controlled Excited-State Intermolecular Proton Transfer: Tuning Photophysical Properties in Aqueous Solution

Pedro J. Pacheco-Liñán, Jesús Fernández-Sainz, Iván Bravo, Andrés Garzón-Ruiz, Carlos Alonso-Moreno, Fernando Carrillo-Hermosilla, Antonio Antiñolo, José AlbaladejoJ. Phys. Chem. C 2018, 122, 17, 9363–9373https://doi.org/10.1021/acs.jpcc.8b02576

Phenyl-guanidine derivatives as potential therapeutic agents for glioblastoma multiforme: catalytic syntheses, cytotoxic effects and DNA affinity

I. Bravo, C. Alonso-Moreno, I. Posadas, J. Albaladejo, F. Carrillo-Hermosilla, V. Ceña, A. Garzón, I. López-Solera, L. Romero-Castillo RSC Advances, 2016, volumen 6, páginas 8267-8274 https://doi.org/10.1039/C5RA17920C

Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(ii) arene complexes

L. M. Broomfield, C. Alonso-Moreno, E. Martin, A. Shafir, I. Posadas, V. Ceña y J. A. Castro-OsmaDalton Transactions, 2017, volumen 46, páginas 16113-16122https://doi.org/10.1039/C7DT03369A

Browse by category

Articles

Books/Chapters

Patents

Reviews

JOURNAL ARTICLES

All Journal Articles

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2021, NOVEL THERAPEUTIC AGENTS

Domínguez-Jurado E, Cimas FJ, Castro-Osma JA, Juan A, Lara-Sánchez A, Rodríguez-Diéguez A, Shafir A, Ocaña A, Alonso-Moreno CPharmaceutics. 2021 Sep 26;13(10):1559https://doi.org/10.3390/pharmaceutics13101559

Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles

JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NANOMEDICINES, REVIEWS

Juan A, Del Mar Noblejas-López M, Arenas-Moreira M, Alonso-Moreno C, Ocaña A. Front Cell Dev Biol. 2022 Feb 3;9:805336. PMID: 35186955; PMCID: PMC8851355 doi: 10.3389/fcell.2021.805336.

Clinical considerations for the design of PROTACs in cancer

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS

Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Mol Cancer. 2022 Mar 7;21(1):67. PMID: 35249548; PMCID: PMC8900451. https://doi.org/10.1186/s12943-022-01535-7

A bis(pyrazolyl)methane derivative against clinical Staphylococcus aureus strains isolated from otitis externa

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS

Ocaña AV, Aguilera-Correa JJ, Domínguez-Jurado E, Pérez-Martínez FC, Pérez-Tanoira R, López-Carretero Y, Masiá-Mondejar J, Castro-Osma JA, Esteban J, Alonso-Moreno C, Molina-Alarcón M, Seguí P. Laryngoscope Investig Otolaryngol. 2022 Jan 18;7(1):283-290. doi:...

Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy

Development of innovative biomedical materials, JOURNAL ARTICLES 2019, NANOMEDICINES

Niza E, Nieto-Jiménez C, Noblejas-López MDM, Bravo I, Castro-Osma JA, Cruz-Martínez F, Buchaca MMS, Posadas I, Canales-Vázquez J, Lara-Sanchez A, Hermida-Merino D, Solano E, Ocaña A, Alonso-Moreno C. Nanomaterials (Basel). 2019 Aug 27;9(9):1208. PMID: 31461998; PMCID:...

Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma

Development of innovative biomedical materials, JOURNAL ARTICLES 2020, NANOMEDICINES

Niza E, Castro-Osma JA, Posadas I, Alonso-Moreno C, Bravo I, Garzón A, Canales-Vázquez J, Ceña V, Lara-Sánchez A, Albaladejo J, Otero A. Pharm. 2019 Mar 10;558:110-119. Epub 2019 Jan 9. PMID: 30639216 doi: 10.1016/j.ijpharm.2018.12.079.